- Home
- WNW vs ADTX Comparison
WNW vs ADTX Comparison
Compare WNW & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- ADTX
- Stock Information
- Founded
- WNW 2015
- ADTX 2017
- Country
- WNW China
- ADTX United States
- Employees
- WNW N/A
- ADTX N/A
- Industry
- WNW Catalog/Specialty Distribution
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- ADTX Health Care
- Exchange
- WNW Nasdaq
- ADTX Nasdaq
- Market Cap
- WNW 5.4M
- ADTX 4.9M
- IPO Year
- WNW 2020
- ADTX 2020
- Fundamental
- Price
- WNW N/A
- ADTX $0.70
- Analyst Decision
- WNW
- ADTX
- Analyst Count
- WNW 0
- ADTX 0
- Target Price
- WNW N/A
- ADTX N/A
- AVG Volume (30 Days)
- WNW 47.6K
- ADTX 359.8K
- Earning Date
- WNW 11-14-2025
- ADTX 11-17-2025
- Dividend Yield
- WNW N/A
- ADTX N/A
- EPS Growth
- WNW N/A
- ADTX N/A
- EPS
- WNW 9.06
- ADTX N/A
- Revenue
- WNW $158,485.00
- ADTX $12,051.00
- Revenue This Year
- WNW N/A
- ADTX $15,768.94
- Revenue Next Year
- WNW N/A
- ADTX N/A
- P/E Ratio
- WNW $0.23
- ADTX N/A
- Revenue Growth
- WNW N/A
- ADTX N/A
- 52 Week Low
- WNW $0.95
- ADTX $0.66
- 52 Week High
- WNW $70.00
- ADTX $464.98
- Technical
- Relative Strength Index (RSI)
- WNW N/A
- ADTX 28.04
- Support Level
- WNW N/A
- ADTX $0.67
- Resistance Level
- WNW N/A
- ADTX $0.77
- Average True Range (ATR)
- WNW 0.00
- ADTX 0.07
- MACD
- WNW 0.00
- ADTX -0.02
- Stochastic Oscillator
- WNW 0.00
- ADTX 3.19
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.